Convert Existing Biomarker Data Into Revenue Capacity

Convert Existing Biomarker Data Into Revenue Capacity Alt

OmicsLayer™ turns disorganized multimodal biomarker data into reusable pharma-ready workflows for cohort selection, responder prediction, patient analysis, and evidence packages.

+EUR 150k–500k/year in additional pharma-partner revenue

  • Sell higher-value work packages instead of one-off analysis requests
  • Package biomarker analysis, cohort selection, trial feasibility evidence, and responder/non-responder stratification into sponsor-ready offerings
  • Expand existing partner accounts with additional evidence-generation services
  • Typical uplift comes from 1–2 new or expanded pharma collaboration packages per year
Integrate now

10–25% improvement in cohort-screening efficiency with lower sponsor-review friction

  • Standardize how cohorts, biomarkers, and supporting evidence are prepared for sponsor-facing review
  • Reduce back-and-forth during pharma and FDA-facing discussions
  • Minimize rework caused by missing provenance, inconsistent outputs, or manually assembled evidence
  • Improve audit-readiness with traceable queries, reusable evidence templates, and structured outputs
Integrate now

EUR 40k–120k/year in higher project margin from reduced manual scientific prep

  • Cut repeated manual work across data science and modality teams
  • Reuse saved queries, exports, metadata links, and evidence templates across projects
  • Reduce time spent on reassembling the same sponsor-facing materials for each request
  • Typical savings are based on avoided internal effort at a fully loaded scientific/data team cost
Integrate now

40–70% faster sponsor response turnaround

  • Answer feasibility questions using searchable cohorts, biomarkers, files, analysis outputs, and provenance
  • Replace manual data assembly with structured, reusable evidence retrieval
  • Shorten response cycles for sponsor requests, cohort questions, and evidence follow-ups
Integrate now
Real implementations of OmicsLayer™ – adapted to each client’s data, infrastructure, and operational needs.

Based on our clients’ experience, OmicsLayer™ saves around €40k–120k/year in avoided manual internal effort.

Start with a free demo on your own data

See how the solution works in practice before committing to deployment or integration.

No-charge initial demo

Secure on-prem/private cloud installation process

Discovery & data audit

  • 1–2 weeks

    Workshops with scientific, data, IT, and compliance teams. We define systems, datasets, permissions, and the first high-value use case.

Data & architecture mapping

  • 2–3 weeks

    We map data flows, metadata, access logic, pipeline dependencies, and integration points.

Build & integration

  • 4–8 weeks

    We connect priority systems, build ingestion/QC workflows, configure the semantic layer, and prepare the AI query interface.

Pilot validation

  • 2–4 weeks

    We test the first use case on real data, validate answer quality, review traceability, and tune workflows with domain experts

Scale & optimization

  • Ongoing

    Add new systems, cohorts, data modalities, dashboards, partner workspaces, and additional AI-assisted workflows.

Deploy once, run in your own environment, and keep full control over your data.

Collaboration Models

Local Deployment

  • One-time deployment of the solution in your local or private environment
  • Setup of the core product block
  • Configuration for your internal workflow
  • Onboarding and handover to your team
Integrate now
Connect your internal data sources, automate ingest, and operationalize the solution at scale.

Collaboration Models

Enterprise Integration

  • Local or private deployment
  • Setup of automated ingest from one selected data source
  • Workflow integration into your internal environment
  • Configuration of one production-ready pipeline
Integrate now
Who it is for

Built for companies where biomedical data already exists

1 Molecular diagnostics companies

Connect variant, assay, phenotype, and evidence data into faster interpretation workflows.

2 Modality-specific design modules

Unify multi-omics and clinical metadata to support discovery, validation, and translational proof-of-concept.

3 Clinical genomics labs

Reduce manual interpretation and reporting burden with traceable, reviewable AI-assisted workflows.

4 Biobanks and research hospitals

Make biospecimen, cohort, omics, and clinical data queryable under strict governance.

5 Pharma translational medicine teams

Move from scattered datasets to reusable biomarker and patient stratification intelligence.

6 CROs and lab networks

Integrate LIMS/ELN, QC, assay outputs, and reporting workflows into one operational intelligence layer.

Get in touch with us.

We’re here to assist you.

Andrew Markov

Delivery Director

Chat in WhatsApp


    Your AI Idea, Our Technical Precision


    From pilot concepts to full-stack pipelines — tell us where you are and where you need to go.




    Drop or upload a file with project requirements in zip, pdf, pptx, docx